In several recent publications the term 'molecular karyotyping' was adopted to describe the use of microarrays for detecting genomic imbalances, in analogy to conventional karyotyping based on analysis of metaphase chromosomes. We argue that this term is a misnomer, because microarraybased techniques do not reveal any details about chromosome number or structure. In addition, the term has already occupied a place in molecular genetics, referring to the separation of chromosomes based on their physical properties, for example, by pulsed-field gel electrophoresis or flow-sorting. As an alternative to 'molecular karyotyping' we propose the more accurate term 'segmental aneuploidy profiling (SAP)'.
In several recent publications, 1 -4 detection of chromosomal imbalances by hybridization of genomic DNA to microarrays has been described as 'molecular karyotyping' (Table 1) . Clearly, the data obtained by microarray-based methods extend and complement those of conventional molecular cytogenetic investigations based on metaphase chromosome-banding techniques and fluorescence in situ hybridization (FISH). Here, we argue that 'molecular karyotyping' is not an adequate description in this context. Both karyotyping and microarray-based comparative genomic hybridization are methods to identify gains and losses throughout the genome in order to provide an explanation for an abnormal phenotype. The resolving power of karyotyping is limited by the representation of the genome in differentially stained chromosome bands. In other words, a gain or loss of genomic DNA can be detected only if the chromosomal banding pattern is affected by the genomic imbalance. By definition, this limits the resolving power of karyotyping to several megabases. In contrast, the resolution provided by microarray-based methods may still be beyond our imagination, reaching the kilobase level when several hundred thousands of SNP markers are used. Microarrays can provide precise information regarding the location, and hence, the gene content, of genomic imbalances. When it comes to making genotype -phenotype correlations in everyday clinical genetic practice and research, microarray-based methods represent a giant leap forward compared to conventional karyotyping. However, may we adopt the name 'molecular karyotyping' for this new methodology?
The term 'molecular karyotyping' has been proposed by Vermeesch 7 The development of lymphocyte culturing and chromosome banding techniques for routine use in the clinical cytogenetics laboratory allows metaphase chromosome structure to be routinely studied at a level of B700 bands, and sophisticated nomenclature has been developed to describe any abnormal karyotype. 7 The term 'molecular karyotyping' proposed by Vermeesch et al 1 is a misnomer because of two intrinsic reasons. First, microarray-based methods do not reveal the number, size or structure (ie 'morphology' cf Levitsky 5 ) of the chromosomes involved. For example, a segmental duplication detected by microarray-based techniques could have been caused by a variety of structural chromosome abnormalities (Table 2a) . Conversely, individuals who harbour a 'normal molecular karyotype', may carry a variety of balanced, but abnormal karyotypes (Table 2b ). This applies, for example, to patients suffering from mental retardation and multiple congenital abnormalities who have a de novo, reciprocal translocation recognizable at metaphase, with one of the chromosomal breaks disrupting a positional candidate gene for the phenotype. In the examples given in Table 3 , cloning and DNA sequence analysis of both translocation breakpoints proved that the translocation was truly reciprocal, and that only one of the breakpoints interrupted a protein coding DNA sequence. Such balanced chromosomal rearrangements, with severe consequences for the patient but of tremendous benefit for the purpose of gene identification, escape detection by whole-genome hybridization to microarrays, even when high-resolution platforms are used. The breakpoints of such rearrangements can be identified using microarrays by hybridization of probes that have been prepared from the flow-sorted, aberrant chromosomes, a technique called 'array painting'. 8 Prior to this, the rearrangements need to be identified by conventional karyotyping.
There is a second intrinsic distinction between both approaches. The karyotype is determined by studying metaphases. Therefore, it is essentially a cell-by-cell approach, enabling, for example, identification of chromosomal mosaicism if two cell lines coexist in an individual, each with its own particular karyotype. In contrast, the DNA-samples used for microarray-based genome analysis represent many cells from an individual. Chromosomal mosaicism can be detected by BAC-based microarray-CGH, but only if the least abundant cell type is present at a frequency of at least B20%.
1 This percentage may drop as techniques are improved, but irrespectively, a much higher sensitivity for detecting mosaicism can be achieved by studying metaphases. For example, the finding of two metaphases with a supernumerary chromosome, each in an independent culture, is conventionally taken among clinical cytogeneticists as sufficient evidence for chromosomal mosaicism. In addition to these two intrinsic arguments, there are also historical reasons for avoiding the use of the term 'molecular karyotyping' as an analogy to metaphase-based karyotyping. The term 'molecular karyotyping' first appeared in the literature during the eighties of the 20th century, when pulsed-field gel electrophoresis (PFGE) enabled physical separation of the megabase-sized interphase, not metaphase, chromosomes of human parasites, such as Leishmania major, 9 Trypanosoma cruzi, 10 and
Plasmodium falciparum. 11 The term is adequately used here because chromosomes are separated, allowing their number and physical size (ie 'morphology' cf Levitsky 5 ) to be determined. Fractionation of chromosomes by PFGE in these species yields an ordered arrangement of the chromosomes. This truly represents a 'molecular karyotype'. It can be used to assign cloned fragments of genomic DNA or cDNAs to a specific chromosome by genomic Southern blot hybridization, which is in perfect analogy to gene mapping by FISH on metaphase chromosomes. This method is being used until the present day, for example in the Trypanosoma cruzi Genome Project for constructing physical maps of the chromosomes of the reference clone CL Brener. 12 In addition, molecular karyotyping of these parasites allowed studying the evolution of their genomes, again in analogy to studies of genome evolution by comparative cytogenetic investigations in species that more easily yield metaphase chromosomes. Thus, the term 'molecular karyotyping' describes a well-defined concept in molecular genetics. In humans, where chromosomes are too large for fractionation by PFGE, the closest equivalent to veritable 'molecular karyotyping' was, again, during the eighties of the 20th century, arrived at by flow cytometry of metaphase chromosomes, generating a 'flow karyotype'. 13 -15 Hybridization of DNA-probes to flow-sorted human metaphase chromosomes spotted on a nitrocellulose filter has been used successfully for gene mapping, 16 in perfect analogy to gene mapping by metaphase FISH. We conclude that metaphase cytogenetics and microarray-based copy number quantification are distinct, but complementary approaches, yielding data that provide clinically meaningful information only when combined. The result of a microarray analysis provides, in essence, a profile of the segmental aneuploidies present in a genome. The resolving power and precision of aneuploidy detection using microarrays is unattainable by chromosome banding. Only studying metaphase chromosomes, using chromosome-banding techniques and FISH, can identify the structural basis and, hence, the mechanism of origin of the chromosomal aneuploidy. Elucidation of the mechanism of origin is crucial for genetic counselling of parents of a child with a genomic imbalance who wish to be informed about the recurrence risk.
As an alternative to 'molecular karyotyping' to describe microarray-based genome investigation, we propose the more precise term 'segmental aneuploidy profiling' (SAP), in accordance with Lindsley et al. 17 By adopting this term, we need to extend the meaning of the term 'aneuploidy' in order to accommodate the recent identification of numerous segmental aneuplodies in healthy individuals. 18 -22 In a classical sense, aneuploidy refers to chromosomes and chromosome segments that are absent from, or exist in addition to, a basic chromosome set, 6 and that in most cases have been recognized because of their association with an abnormal phenotype. The classical meaning of the term relies on the existence of a 'basic chromosome set' (a perfectly euploid genome) in healthy individuals. As shown recently, numerous segmental aneuploidies (also termed 'copy number polymorphisms' or 'large-scale copy number variations') are shared between unrelated, apparently healthy humans. 18 -20 These genomic variations have also been found in commonly used inbred laboratory mouse strains. 21 -22 The regions of copy number variation thus identified may be as large as several hundred kilobases of DNA, and many contain protein coding genes. Whereas the phenotypic relevance of these genomic imbalances is unknown, it is clear that a perfectly euploid genome may not exist in mice and men. Of course, a perfectly euploid genome would be the ideal reference sample for detecting segmental aneuploidies by array-CGH. For this purpose we have created a synthetic diploid human genome by combining equal amounts of genomic DNA from 50 healthy subjects of the same sex. 23 In the absence of an euploid genome, the classical meaning of 'aneuploidy' requires reconsideration. We propose that the term 'segmental aneuploidy' refers to all deviations from an ideal, perfectly diploid chromosome complement as revealed by hybridization of genomic DNA to microarrays. These include both copy number changes of apparent clinical relevance (as defined by their occurrence in one particular patient), and those that are, apparently, not clinically relevant (as defined by their occurrence in multiple, unrelated, healthy subjects). This is an appropriate extension of the classical meaning of the term aneuploidy, allowing to accommodate data generated by microarraybased genomic hybridization. 
